Jennifer A. Palmer, MS
Articles
September 7th 2009
Patient Adherence: A Blind Spot in Cost-Effectiveness Analyses?
Allison B. Rosen, MD, MPH, ScD Alicen B. Spaulding, MPH Dan Greenberg, PhD Jennifer A. Palmer, MS Peter J. Neumann, ScD
A systematic literature review from 1998 to 2003 showed that few cost-effectiveness analyses of self-administered medications model suboptimal medication adherence.
April 15th 2008
A Strategic Plan for Integrating Cost-effectiveness Analysis Into the US Healthcare System
Peter J. Neumann, ScD Jennifer A. Palmer, MS Norman Daniels, PhD Karen Quigley, MPH Marthe R. Gold, MD Schumarry Chao, MD, MBA
A panel composed of medical and pharmacy directors expressed strong support for a greater role for cost-effectiveness analysis in US health policy decisions.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: November 1st 2024 | Updated: November 21st 2024
Table Multiple Myeloma Trials November 2024
